The most frequent cause of transient ischemic attacks (TIAs) is atherosclerosis, the gradual buildup of fatty deposits inside artery walls that narrows blood vessels and restricts blood flow to the brain. This process can trigger a TIA either by sending small clots or debris downstream from a diseased artery or by temporarily choking off flow through a narrowed vessel. Beyond atherosclerosis, several other mechanisms account for a significant share of TIAs, and in roughly 30% to 40% of cases, no definitive cause is ever found.
How Atherosclerosis Causes a TIA
Atherosclerosis develops over years as cholesterol, calcium, and inflammatory cells accumulate inside artery walls, forming plaques. In the context of TIAs, the most clinically important location is the carotid arteries, the two large vessels on either side of the neck that supply most of the brain’s blood. When a plaque in the carotid artery becomes unstable, small fragments or blood clots can break loose and travel into smaller brain arteries, temporarily blocking flow. The blockage resolves on its own, usually within minutes, and symptoms disappear. That’s what distinguishes a TIA from a full stroke, where the blockage persists long enough to kill brain tissue.
Even though large-artery atherosclerosis is the single most recognized mechanism, the degree of narrowing varies widely among TIA patients. One study using Doppler ultrasound found that only about 5% of TIA patients had carotid narrowing severe enough to warrant surgical consideration. That means many atherosclerosis-related TIAs come from plaques that are dangerous not because of their size but because of their instability. A relatively small, inflamed plaque can shed debris just as readily as one that blocks most of the artery.
Atherosclerosis doesn’t only affect the carotid arteries. It can also develop in the vertebral arteries at the back of the neck, the arteries at the base of the brain, and the tiny perforating vessels deep inside the brain. When small vessel disease affects those deep vessels, it can cause what’s known as a lacunar TIA. In these cases, a microatheroma (a miniature plaque) forms at the opening of a tiny artery and briefly interrupts flow to a small but critical area of brain tissue.
Cardioembolism and Atrial Fibrillation
The second major cause of TIAs is a blood clot that forms in the heart and travels to the brain. The most common heart condition behind this is atrial fibrillation (AFib), an irregular heart rhythm that allows blood to pool and clot in the upper chambers of the heart. Between 2004 and 2013, the proportion of TIA patients who also had AFib rose from about 12% to 17%, likely reflecting both an aging population and better detection of the arrhythmia.
Cardioembolic TIAs tend to be clinically significant because the clots originating from the heart are often larger than those shed by a neck plaque, which means they’re more likely to cause a full stroke if they don’t dissolve quickly. If AFib is identified as the cause, treatment shifts from antiplatelet medications to blood thinners that specifically target the clotting cascade in the heart.
When No Cause Is Found
Despite thorough testing, doctors cannot identify a definitive cause in an estimated 30% to 40% of ischemic strokes and TIAs. These are labeled “cryptogenic.” In many of these cases, undetected AFib is suspected. The arrhythmia can be intermittent, firing only briefly and unpredictably, so a standard heart monitor worn for 24 or 48 hours may miss it entirely. Longer monitoring periods, sometimes weeks, catch more cases. Other hidden causes include small holes between the heart’s upper chambers (patent foramen ovale) and non-obstructive plaques in the aorta that shed tiny clots.
Risk Factors That Drive All Causes
Regardless of the specific mechanism, the same handful of conditions dramatically increase TIA risk. High blood pressure is the single most important modifiable risk factor because it accelerates plaque formation and damages small vessels. Diabetes roughly triples the overall incidence of stroke compared to the general population, and the Framingham Heart Study found that people with glucose intolerance had double the risk of brain infarction, with an even higher relative risk in women than in men.
Racial and ethnic disparities are striking. African Americans face roughly 2.4 times the stroke incidence of the general population, and Caribbean Hispanics about twice the incidence, patterns driven in part by higher rates of both diabetes and hypertension in these groups. Smoking, high cholesterol, physical inactivity, and obesity round out the major controllable risk factors.
Why a TIA Is a Medical Emergency
A TIA is sometimes called a “warning stroke,” and the numbers back that up. The risk of a full stroke in the 90 days following a TIA ranges from 10% to 20%, and the most dangerous window is the first 48 hours, when 2% to 5% of recurrent strokes occur. That compressed timeline is why emergency departments treat TIAs with the same urgency as completed strokes.
Doctors use a scoring tool called the ABCD2 score to estimate short-term stroke risk after a TIA. It assigns points for age 60 or older, elevated blood pressure, diabetes, the type of symptoms (weakness scores highest, followed by speech difficulty), and how long the symptoms lasted. The maximum score is 7, and higher scores indicate a greater need for urgent intervention and monitoring.
How TIAs Are Defined Today
The traditional definition of a TIA was purely time-based: neurological symptoms lasting less than 24 hours. That cutoff is still widely used, but brain imaging has complicated the picture. When researchers performed diffusion-weighted MRI on over 1,000 patients classified as having a TIA by the 24-hour rule, about 14% showed evidence of actual brain tissue damage. Those patients with visible damage on MRI had a significantly higher 10-year risk of recurrent stroke (roughly 2.7 times the risk) compared to those with a clean scan. This means some events labeled as TIAs are, biologically speaking, small strokes, and knowing the difference helps predict what comes next.
Conditions Commonly Mistaken for TIAs
Not every episode of sudden neurological symptoms is a TIA. About 20% of patients referred with a suspected TIA turn out to have migraine aura instead. Migraine aura typically produces “positive” symptoms like shimmering lights, zigzag patterns, or tingling that spreads gradually across part of the body over several minutes. A TIA, by contrast, causes “negative” symptoms: sudden loss of vision, numbness, or weakness that is maximal right from the start.
Seizures, fainting episodes, and anxiety-related symptoms are other frequent mimics. Seizures tend to involve jerking movements, lip smacking, or loss of awareness and typically last under two minutes. Fainting causes lightheadedness, darkened vision, and brief loss of consciousness, usually for seconds. The key distinguishing feature of a true TIA is an abrupt onset of loss of function (not added sensation) that resolves gradually over minutes to an hour, almost always in less than 60 minutes.
Treatment After a TIA
For TIAs not caused by a heart rhythm problem, the standard initial treatment is a short course of dual antiplatelet therapy, meaning two medications that prevent blood cells from clumping together. This combination is typically started within 24 hours of symptom onset and continued for about 21 days, after which most patients transition to a single antiplatelet medication for long-term prevention. In selected high-risk patients, the dual combination may be extended up to 90 days. Even with this aggressive approach, about 8% of patients in clinical trials experienced a recurrent stroke within 90 days, underscoring that medication alone isn’t enough without also managing blood pressure, blood sugar, cholesterol, and lifestyle factors.
When a significantly narrowed carotid artery is identified as the cause, a surgical procedure to remove the plaque or a stent to hold the artery open may be recommended. For TIAs caused by atrial fibrillation, blood thinners replace antiplatelet therapy as the primary prevention strategy.